A 35-year-old man presents with new-onset symmetrical small joint pain and morning stiffness lasting more than 1 hour for 3 months. Examination reveals synovitis of the metacarpophalangeal and proximal interphalangeal joints bilaterally. ESR and CRP are elevated, and rheumatoid factor and anti-CCP antibodies are positive. What is the most appropriate initial disease-modifying therapy?